Copy Link Print Information

Emfizatamab

(Synonyms: GNC-038)
고객리뷰

Based on 1 Customer Validation

Emfizatamab (GNC-038) is a monoclonal antibody against CD19/CD3E/TNFRSF9/PD-L1. Emfizatamab exhibits antitumor activity, being capable of activating CD3 and 4-1BB signals on T cells, as well as targeting the high expression of CD19 or PD-L1 on tumor cells. Emfizatamab functions as a CD19-specific T cell engager by mediating direct antitumor activity. Emfizatamab can also overcome the inhibition of T cells by PD-L1. Emfizatamab can be used in the research of tumors such as R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 95.495%
  • CAS No.: 2559704-23-1
  • 분자량:303.229 kDa
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Emfizatamab Chemical Structure
    Emfizatamab Chemical Structure
CAS No.: 2559704-23-1
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Emfizatamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

All TNF Receptor Isoforms

More

All Interleukin Related Isoforms

More
Keywords
100 mg

견적 받기 해외재고보유

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.

  • 1/16

    Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.

  • 1/16

    Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.

  • 1/16

    Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.

  • Emfizatamab Chemical Structure
    1/16
  • Emfizatamab
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.
  • Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.
  • Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.
  • Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.
  • (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)